Merkliste 
 1 Ergebnisse 
 
1

Cost-effectiveness analysis of dostarlimab plus carboplatin..:

Maojin You ; Xiaoling Zeng ; Jinrong Zhang...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1267322/full.  , 2023